This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
Brookfield Renewable (BEP) Surges 5.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Brookfield Renewable (BEP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BEPPositive Net Change PNWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beam Therapeutics (BEAM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Beam Therapeutics (BEAM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
BEAMPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Down 22.8% in 4 Weeks, Here's Why Commvault (CVLT) Looks Ripe for a Turnaround
by Zacks Equity Research
Commvault (CVLT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CVLTPositive Net Change
rsi stock-price-movement
Down 8.8% in 4 Weeks, Here's Why RenaissanceRe (RNR) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for RenaissanceRe (RNR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
RNRNegative Net Change
rsi stock-price-movement
Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)
by Zacks Equity Research
Microbot Medical (MBOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
MBOTPositive Net Change
rsi stock-price-movement
Down 15.2% in 4 Weeks, Here's Why Vital Farms (VITL) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Vital Farms (VITL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
VITLNegative Net Change
rsi stock-price-movement
Burlington Stores (BURL) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
BURLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Here's Why Momentum in MDxHealth SA (MDXH) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, MDxHealth SA (MDXH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
MDXHPositive Net Change
price-performance stock-price-change stock-price-movement
Envela (ELA) Moves 8.6% Higher: Will This Strength Last?
by Zacks Equity Research
Envela (ELA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ELAPositive Net Change SIGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Janux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last?
by Zacks Equity Research
Janux Therapeutics (JANX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
JANXPositive Net Change TRDAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Brookfield Renewable (BEPC) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Brookfield Renewable (BEPC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BEPCPositive Net Change VTLEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
YPF Sociedad Anonima (YPF) Soars 23.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
YPF Sociedad Anonima (YPF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
YPFPositive Net Change BPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Burford Capital (BUR) Soars 5.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Burford Capital (BUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BURPositive Net Change TONXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Transportadora De Gas Ord B (TGS) Moves 36.8% Higher: Will This Strength Last?
by Zacks Equity Research
Transportadora De Gas Ord B (TGS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
TGSPositive Net Change MPLXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
McKesson (MCK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MCKNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About QuantumScape (QS) Rating Upgrade to Buy
by Zacks Equity Research
QuantumScape (QS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
QSPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MEDPPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Farmers National (FMNB) Upgraded to Buy: Here's Why
by Zacks Equity Research
Farmers National (FMNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FMNBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Emerson Electric (EMR) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Emerson Electric (EMR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EMRPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Skyworks (SWKS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Skyworks (SWKS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SWKSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Acadia (ACAD) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Acadia (ACAD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ACADNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Nordea Bank (NRDBY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Nordea Bank (NRDBY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NRDBYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
West Bancorp (WTBA) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
West Bancorp (WTBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
WTBANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
MasterCraft Boat Holdings, Inc. (MCFT) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
MasterCraft Boat Holdings, Inc. (MCFT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MCFTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
EastGroup Properties (EGP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
EGPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines